| | |
C.H. Unnikrishnan 11:56 PM | September 10,2009
Firm to take on rivals by launching versions of top-selling drugs, to address both chronic and infectious diseases
|
|
PTI 12:38 PM | August 02,2009
In the past five years, drugs worth around $50 billion went off-patent in the US, which, along with a doubling of generic alternatives in the market
|
|
02:44 PM | July 30,2008
Hormosan develops licences and markets a range of generics in Germany and specialises in the supply of pharmaceutical products for the central nervous system
|
|
Bhuma Shrivastava 02:15 AM | July 08,2008
The proposal had the potential to hurt sales of generic or non-patented drug makers and potentially could have delayed introduction of cheaper drug copies in the market
|
|
02:31 PM | June 25,2008
The company has the approval to make and market 450 mg tablets of valganciclovir hydrochloride, which prevents unnecessary cases of blindness
|
|
Baiju Kailesh 12:07 AM | June 12,2008
While the Indian economy too faces the challenges of inflation and slower growth, it is expected to continue growing much faster than larger ones such as the US
|
|
Bhuma Shrivastava 10:42 PM | May 02,2008
Those launching copies of a patented drug run the risk of being sued; industry says courts should deal with this
|
|
C.H. Unnikrishnan 12:11 AM | April 25,2008
Local firms can import generics made in least developed countries without authorization of the patent holder
|
|
Bharghavi Nagaraju / Reuters 12:01 AM | November 08,2007
The company’s share price dropped 0.91% on BSE in anticipation of the generics arm demerger
|
|
PTI 05:40 PM | October 05,2007
Clarithromycin is used to treat certain infections caused by bacteria, such as pneumonia, bronchitis, and infections of ears, sinuses, skin, and throat
|
|
Mark to Market | Mobis Philipose 11:55 PM | October 04,2007
Despite the unimpressive Q2 numbers, analysts are encouraged by the firm’s acquisition strategies and positive developments in its generics business
|
|
02:32 PM | September 13,2007
Firm is only generic maker to get FDA okay for this product; approval is also first for its OTC business in US
|
|
Sanjiv Kaul 12:14 AM | September 06,2007
A very different set of players are engaging in value creation; big companies have not been very responsive
|
|
Quick Edit 12:00 AM | September 06,2007
Innovative research is where real potential for future growth of the pharma sector lies
FIND MORE ARTICLES ON:
Pharma ResearchGenerics
|
|
04:40 PM | June 25,2007
Acquisition marks Indian pharma major’s foray into the branded generics market in Brazil
|
|